Verified Nov 2026
Batteries & E-Mobility
·
Bergisch Gladbach, North Rhine-Westphalia
·
Since 1989
Miltenyi Biotec is a biotechnology company headquartered in Bergisch Gladbach, Germany, founded in 1989. It employs roughly 1,000 to 5,000 people, with an estimated revenue band of $500 million to $1 billion. The company is privately held and serves research scientists, clinical researchers, and biopharma companies, with a focus on cell and gene therapy, immunology, and cancer research. It is working toward the global clinical use of its Atla-cel cell therapy, which originated in New Zealand research, and it has expanded its Teterow site in Germany, where it broke ground in December 2025.
Miltenyi Biotec at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1989
Headquarters
Bergisch Gladbach, North Rhine-Westphalia
Certifications
ISO 13485 · ISO 9001
Import activity
137
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
137
Named foreign suppliers
8
Top origins
Germany · Belgium · Netherlands · Mexico
Shared foreign counterparties do not establish that these companies buy from Miltenyi Biotec.
What this tells a buyer
Trade records were not available for this company, so no shipment or origin data can be reported; the company has announced expansion at its Teterow site and a partnership with Verismo Therapeutics in 2025.
Core capabilities include MACS cell separation technology, flow cytometry instruments, cell culture and sample preparation solutions, lentiviral vector production, and GMP-oriented cell processing, certified to ISO 13485 and ISO 9001.
The company is privately held and works with clinical and biopharma partners such as Verismo Therapeutics on cell therapy programs.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & active
37 years in operation (founded 1989).
Holds ISO 13485, ISO 9001 certification(s) per public sources.
Overview
Miltenyi Biotec is a biotechnology company headquartered in Bergisch Gladbach, Germany, founded in 1989. It employs roughly 1,000 to 5,000 people, with an estimated revenue band of $500 million to $1 billion. The company is privately held and serves research scientists, clinical researchers, and biopharma companies, with a focus on cell and gene therapy, immunology, and cancer research. It is working toward the global clinical use of its Atla-cel cell therapy, which originated in New Zealand research, and it has expanded its Teterow site in Germany, where it broke ground in December 2025.
At a glance
Attribute | Detail |
|---|---|
Founded | 1989 |
Headquarters | Bergisch Gladbach, North Rhine-Westphalia |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 · ISO 9001 |
What Miltenyi Biotec makes
Core capabilities include MACS cell separation technology, flow cytometry instruments, cell culture and sample preparation solutions, lentiviral vector production, and GMP-oriented cell processing, certified to ISO 13485 and ISO 9001.
Certifications
Miltenyi Biotec is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — miltenyibiotec.com
ISO 9001 — miltenyibiotec.com
Trade and customs footprint
Trade records were not available for this company, so no shipment or origin data can be reported; the company has announced expansion at its Teterow site and a partnership with Verismo Therapeutics in 2025. US customs bill-of-lading records list 137 inbound shipments across 8 foreign suppliers, with top origins including Germany · Belgium · Netherlands · Mexico.
Latest developments
2026-08-19 — From breakthrough research in New Zealand to the global stage, Atla-cel is one step closer to reaching patients worldwide. 🌍 | Miltenyi Biotec (linkedin.com)
2026-07-24 — Notice of Intent to Sole Source – Miltenyi Biotec, Inc - National Institutes of Health OLAO Bid & RFP - Due Aug 1, 2026 | Starbridge (starbridge.ai)
2025-12-19 — Yesterday, we broke ground on the next stage of growth at our Miltenyi Biotec Teterow site. We were honored to welcome Minister President Manuela Schwesig and other distinguished guests to celebrate this … | Miltenyi Biotec (linkedin.com)
2025-09-25 — Verismo Therapeutics Announces Partnership with Miltenyi Biotec to Support Advancing Clinical Programs (prnewswire.com)
2025-04-02 — Pioneer and Miltenyi Biotec Unveil Strategic Partnership at Victoria House - Pioneer Group (thepioneergroup.com)
Facilities
Miltenyi Biotec is headquartered in Bergisch Gladbach, North Rhine-Westphalia. Public sources also reference these locations:
Germany — ca.gov
Gaithersburg, MD — miltenyibiotec.com
Company details
The company is privately held and works with clinical and biopharma partners such as Verismo Therapeutics on cell therapy programs. Miltenyi Biotec was founded in 1989, has an estimated 1,000-5,000 employees, and is headquartered in Bergisch Gladbach, North Rhine-Westphalia. On the LightSource stability read it is rated "Established & active": 37 years in operation (founded 1989). Holds ISO 13485, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Miltenyi Biotec make?
Miltenyi Biotec is a biotechnology company headquartered in Bergisch Gladbach, Germany, founded in 1989. It employs roughly 1,000 to 5,000 people, with an estimated revenue band of $500 million to $1 billion. The company is privately held and serves research scientists, clinical researchers, and biopharma companies, with a focus on cell and gene therapy, immunology, and cancer research. It is working toward the global clinical use of its Atla-cel cell therapy, which originated in New Zealand research, and it has expanded its Teterow site in Germany, where it broke ground in December 2025.
Where is Miltenyi Biotec headquartered?
Miltenyi Biotec is headquartered in Bergisch Gladbach, North Rhine-Westphalia (68 Friedrich-Ebert-Strasse, Bergisch Gladbach, North Rhine-Westphalia, 51429).
When was Miltenyi Biotec founded?
Miltenyi Biotec was founded in 1989.
How big is Miltenyi Biotec?
Miltenyi Biotec has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
What certifications does Miltenyi Biotec hold?
Miltenyi Biotec lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Does Miltenyi Biotec import from overseas suppliers?
US customs bill-of-lading records show 137 inbound shipments for Miltenyi Biotec, with top origins including Germany · Belgium · Netherlands · Mexico.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.